BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 23, 2011
View Archived Issues
KAI Pharmaceuticals releases clinical data on KAI-4169
Read More
Bendamustine evaluated in anaplastic glioma
Read More
Promising preclinical data presented on GBR-401
Read More
Potential new biomarker for the diagnosis of giant cell arteritis
Read More
Plasma biomarker of small cell lung cancer identified
Read More
DNA polymerase eta levels predict oxaliplatin efficacy in esophageal cancer
Read More
Bafetinib as potential therapeutic for Parkinson's disease
Read More
Merck & Co. designs novel beta3-adrenoceptor agonists
Read More
New lysophospholipid S1P1 receptor modulators disclosed by Allergan
Read More
Phase III study of DiaPep277 in type 1 diabetes meets primary endpoint
Read More
Selecta Biosciences commences clinical trial of vaccine for smoking cessation
Read More
New steroidal lactones from M. crassissima disclosed by PharmaMar
Read More
Portola completes financing round
Read More
Pierre Fabre Medicament gains approval to market Joncia in Australia
Read More
Pfizer to acquire Excaliard Pharmaceuticals
Read More
Japanese researchers prepare novel Toll-like receptor antagonists
Read More
Compounds that modulate skeletal muscle contractility disclosed by Cytokinetics
Read More
Cara Therapeutics starts first clinical study of oral CR-845
Read More
Swissmedic approves Celgene's Revlimid
Read More
GLPG-0634 shows signs of efficacy and safety in phase II study
Read More
Trimel Pharmaceuticals provides update on CompleoTRT study
Read More
EMA committee recommends approval of new indication for Herceptin
Read More
Phase III study investigates CXA-201 and metronidazole for intra-abdominal infections
Read More
Celgene to discontinue study of treatment regimen for castration-resistant prostate cancer
Read More
Landmark study to evaluate regenerative stem cell strategy to treat MS
Read More
Milestone reached in PsychoGenics/Roche drug discovery collaboration
Read More
FDA accepts for review Regeneron's sBLA for Arcalyst
Read More